Literature DB >> 8628457

Coexistence of migraine and idiopathic intracranial hypertension without papilledema.

N T Mathew1, K Ravishankar, L C Sanin.   

Abstract

Eighty-five patients with refractory transformed migraine type of chronic daily headache (CDH) had spinal tap as a part of diagnostic work-up. Twelve had increased intracranial pressure without papilledema, transient visual obscurations, or visual field defects. The headache profile of these 12 patients was not different from that of transformed migraine type of CDH. Acute headache exacerbations responded to specific antimigraine agents such as ergotamine, dihydroergotamine (DHE), and sumatriptan, whereas prophylactic antimigraine medications were only partially helpful. Addition of agents such as acetazolamide and furosemide, after the diagnosis of increased intracranial pressure, resulted in better control of symptoms. These observations suggest a link between migraine and idiopathic intracranial hypertension that needs further research. In refractory CDH with migrainous features, a spinal tap to exclude coexistent idiopathic intracranial hypertension without papilledema may be indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628457     DOI: 10.1212/wnl.46.5.1226

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  48 in total

Review 1.  New daily persistent headache.

Authors:  Peter J Goadsby; Christopher Boes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 2.  Pseudotumor cerebri.

Authors:  Pietro Spennato; Claudio Ruggiero; Raffaele Stefano Parlato; Maria Consiglio Buonocore; Antonio Varone; Emilio Cianciulli; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2010-08-19       Impact factor: 1.475

Review 3.  Sinus venous stenosis, intracranial hypertension and progression of primary headaches.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Pasquale Persico; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

4.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

Review 5.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

6.  Alterations in the cerebral venous circulation as a cause of headache.

Authors:  Elio Agostoni; Angelo Aliprandi
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 7.  Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Authors:  Roberto De Simone; Angelo Ranieri; Chiara Fiorillo; Leonilda Bilo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

Review 8.  MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and pathophysiologic mechanisms.

Authors:  N Passi; A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

9.  Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache.

Authors:  F Bono; D Messina; C Giliberto; D Cristiano; G Broussard; S D'Asero; F Condino; L Mangone; C Mastrandrea; F Fera; A Quattrone
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

Review 10.  Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm.

Authors:  Vincenzo Bonavita; Roberto De Simone; Angelo Ranieri
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.